Cancer Genetics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
02 nov. 2020 16h00 HE
|
Cancer Genetics, Inc.
Rutherford, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics” or “the Company”), a leader in drug discovery and preclinical oncology and immuno-oncology...
Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million
28 oct. 2020 21h55 HE
|
Cancer Genetics, Inc.
Rutherford, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics”), a leader in drug discovery and preclinical oncology and immuno-oncology services,...
Cancer Genetics, Inc. Announces $2.0 Million Bought Deal Offering
28 oct. 2020 17h54 HE
|
Cancer Genetics, Inc.
Rutherford, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics”), a leader in in drug discovery and preclinical oncology and immuno-oncology services,...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, ARA, MVC, and CGIX Mergers
19 oct. 2020 15h24 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Eidos Therapeutics, Inc. (NASDAQ GS: EIDX) regarding possible breaches of...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, VRTU, CBMG, and CGIX Mergers
14 oct. 2020 13h14 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Eidos Therapeutics, Inc. (NASDAQ GS: EIDX) regarding possible breaches of...
Moore Kuehn Encourages BDGE, CBMG, CGIX, and BMCH Investors to Contact Law Firm
24 sept. 2020 10h48 HE
|
Moore Kuehn
NEW YORK, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of AIMT, BMCH, BYFC, and CGIX Mergers
23 sept. 2020 15h00 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Aimmune Therapeutics, Inc. (NASDAQ GS: AIMT) regarding possible breaches of...
Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference
10 sept. 2020 08h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...
Cancer Genetics and StemoniX Announce Joint Proof-of-Concept Program
03 sept. 2020 08h00 HE
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., and MAPLE GROVE, MN, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, and...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of BMCH, BYFC, CGIX, and PTI Mergers
02 sept. 2020 20h00 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: BMC Stock Holdings, Inc. (NASDAQ GS: BMCH) regarding possible breaches of...